Dr. Scott Gottlieb on concerns over drug trials in China

Former FDA Commissioner Dr. Scott Gottlieb joins 'Squawk Box' to discuss the FDA's selection of seven companies for its ...

Dr. Gottlieb on new FDA leadership: Having strong career leadership helps you get more policy done

Former FDA Commissioner Dr. Scott Gottlieb joins 'Squawk Box' to discuss the FDA's push to innovate, what to expect under new ...
American Enterprise Institute

Discussing GLP-1’s and the drug approval process: Gottlieb on CNBC’s “Squawk Box”

Senior Fellow Scott Gottlieb discusses GLP-1’s and the drug approval process: Gottlieb on CNBC’s “Squawk Box.” ...
American Enterprise Institute

Discussing the FDA’s new rare disease framework: Gottlieb on CNBC’s ‘Squawk Box’

Senior Fellow Scott Gottlieb discusses the FDA’s new rare disease framework on CNBC’s ‘Squawk Box.’ ...
CNBC

Larger trials likely needed to prove Tylenol, Autism risk correlation: Dr. Scott Gottlieb

CNBC’s “Squawk Box” team discusses the Washington Post's reporting that the Trump administration is planning to tie Tylenol use during pregnancy to the risk of Autism with Dr. Scott Gottlieb, CNBC ...